175 related articles for article (PubMed ID: 38005984)
1. An Evaluation of Urease A Subunit Nanocapsules as a Vaccine in a Mouse Model of
Skakic I; Francis JE; Dekiwadia C; Aibinu I; Huq M; Taki AC; Walduck A; Smooker PM
Vaccines (Basel); 2023 Oct; 11(11):. PubMed ID: 38005984
[TBL] [Abstract][Full Text] [Related]
2. Solid Lipid Nanoparticles Delivering a DNA Vaccine Encoding
Francis JE; Skakic I; Majumdar D; Taki AC; Shukla R; Walduck A; Smooker PM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256149
[TBL] [Abstract][Full Text] [Related]
3. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
4. Protein-only nanocapsules induce cross-presentation in dendritic cells, demonstrating potential as an antigen delivery system.
Taki AC; Francis JE; Skakic I; Dekiwadia C; McLean TR; Bansal V; Smooker PM
Nanomedicine; 2020 Aug; 28():102234. PubMed ID: 32522709
[TBL] [Abstract][Full Text] [Related]
5. Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research.
Skakic I; Taki AC; Francis JE; Dekiwadia C; Van TTH; Joe CCD; Phan T; Lovrecz G; Gorry PR; Ramsland PA; Walduck AK; Smooker PM
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675791
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
8. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
9. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T
Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
11. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
Xie W; Zhao W; Zou Z; Kong L; Yang L
Helicobacter; 2021 Jun; 26(3):e12807. PubMed ID: 33847026
[TBL] [Abstract][Full Text] [Related]
12. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
13. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
14. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism.
Lv X; Yang J; Song H; Li T; Guo L; Xing Y; Xi T
Vaccine; 2014 Sep; 32(41):5343-52. PubMed ID: 25093281
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
17. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
18. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.
Gómez-Duarte OG; Lucas B; Yan ZX; Panthel K; Haas R; Meyer TF
Vaccine; 1998 Mar; 16(5):460-71. PubMed ID: 9491500
[TBL] [Abstract][Full Text] [Related]
19. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.
Lee MH; Roussel Y; Wilks M; Tabaqchali S
Vaccine; 2001 Jul; 19(28-29):3927-35. PubMed ID: 11427267
[TBL] [Abstract][Full Text] [Related]
20. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
